[go: nahoru, domu]

US3682160A - Physiological signal transmitter for use inside the body - Google Patents

Physiological signal transmitter for use inside the body Download PDF

Info

Publication number
US3682160A
US3682160A US866818A US3682160DA US3682160A US 3682160 A US3682160 A US 3682160A US 866818 A US866818 A US 866818A US 3682160D A US3682160D A US 3682160DA US 3682160 A US3682160 A US 3682160A
Authority
US
United States
Prior art keywords
electrode
medical transmitter
voltage
medical
oscillator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US866818A
Inventor
Norio Murata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panasonic Holdings Corp
Original Assignee
Matsushita Electric Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matsushita Electric Industrial Co Ltd filed Critical Matsushita Electric Industrial Co Ltd
Application granted granted Critical
Publication of US3682160A publication Critical patent/US3682160A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/42Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0031Implanted circuitry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/07Endoradiosondes
    • A61B5/073Intestinal transmitters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1405Electrodes having a specific shape
    • A61B2018/1435Spiral

Definitions

  • a miniature medical transmitter detects a physiological variable in a human body and transmits a signal to a receiver placed at the outside of a human body, more particularly to an orally swallawable minature transmitter for measuring pH value or any other variable in a gastro-intestinal tract.
  • the transmitter comprises detecting means for generating a voltage relating to a physiological variable in a human body, limiting network means, a storing capacitor and oscillator means, and its operation is based on an arrangement wherein the voltage from the detecting means ac;
  • the transmitter does not require conventional power supply means such as battery means and external energy sender means placed outside the body.
  • FIG. 1 is a block diagram illustrative of the medical transmitter for measuring a physiological variable in a human body in accordance with the present invention
  • FIG. 2 is an embodiment of the medical transmitter according to FIG. 1,
  • FIG. 3 is a voltage waveform in the medical transmitter according to FIG. 2,
  • FIG. 4 is a graph showing the relationship between a voltage due to a physiological variable and various time intervals produced bythe medical transmitter according to FIG. 2,
  • FIG. 5 is one embodiment of a preferable circuit diagram of the medical transmitter according to the present invention.
  • FIG. 6 is a series of waveforms generated by the medical transmitter of FIG. 5,
  • FIG. 7 is a graph showing the relationship between pH and electromotiveforce (EMF) of an antimony electrode with reference to a saturated-calomel electrode
  • FIGS. 8-13 illustrate modified embodiments of the medical transmitter according to the present invention.
  • a medical transmitter comprises detecting means for generating a voltage relating to a physiological variable in a human body, limiting network means, a storing capacitor and oscillator means, and its operation is based on the novel arrangement wherein the voltage from the detecting means activates the oscillator means and, at the same time, modulates the oscillator means.
  • the medical transmitter adapted for transmission of an electric signal corresponding to a physiological variable in a human body, in accordance with the present invention, comprises detecting means ll having two detecting terminals 5 and 6 provided with detected voltage E relating to the physiological variable; limiting network means 2 which has two input terminals 5' and 6 connected with the two detecting terminals 5 and 6 and which has two output terminals 7 and 8' provided with a limiting current, I therefrom; a storing capacitor 3 of a capacitance, C,,, which is connected at two terminals 7" and 8", with the two output terminals 7 and 8'; and oscillator means 4 which has two energizing terminals 7 and 8 connected with the two terminals 7" and 8" of the storing capacitor 3 and which contains no battery or the like.
  • the oscillator means 4 starts to generate an oscillation in an oscillation frequency, f, when a voltage between the two energizing terminals 7 and 8 rises up to a starting voltage V and the oscillator means 1 stops the oscillation when the voltage between the two energizing terminals 7 and 8 falls down to a stopping voltage, V,,.
  • the oscillator means 4 has a leakage current I to flow therethrough upon the cease of the oscillation and an actuating current I to flow therethrough during the oscillation, whereby the following relation holds:
  • I 3 l)mrl.r u)mln can accomplish a medical transmitter satisfying the relation (1) by controlling the detected voltage E and the limiting network means 2.
  • the medical transmitter satisfying the relation (1) always operates in an intermittent oscillation.
  • the oscillator means 4 supplied with an energizing voltage V lower than the starting voltage V is not oscillating, a limiting current I is larger than a leakage current 1,. Accordingly, the storing capacitor 3 continues to be charged by a current due to a difference between a limiting current I and a leakage current I until an energizing voltage V rises up to the starting voltage V, and then an oscillation takes place in the oscillator means 4.
  • an actuating current 1 is larger than a limiting current 1. Accordingly, the storing capacitor 3 continues to discharge a charge stored in the storing capacitor 3 at a current due to a difference between an actuating current 1., and a limiting current 1 until an energizing voltage V falls down to the stopping voltage V,, and then the oscillation ceases.
  • a time interval when the oscillator means 4 is not in oscillation and a time interval when the oscillator means 4 is oscillating will be defined as a non-oscillating period t, and an oscillating period It respectively.
  • a time interval which is the sum of the non-oscillating period t and the oscillating period will be defined as an intermittent oscillation period, T.
  • a non-oscillating period t and an oscillating period t are a function of the limiting current I which is a function of the detected voltage E. Therefore, the intermittent oscillation period T of the medical transmitter is also clearly a function of the detected voltage E. Accordingly, the medical transmitter according to the present invention transmits, an electric signal corresponding to a physiological variable in a human body.
  • the intermittent oscillation period T of the medical transmitter is required to be much shorter than a time interval corresponding to one cycle of the highest frequency in a physiological variable.
  • the use of an oscillation frequency f of medium frequency or more can easily satisfy this requirement, because the highest frequency of a physiological variable is usually not more than about lOOI-Iz.
  • an energizing voltage V has, for example, a waveform as shown in FIG. 3.
  • a time interval (a) to (b) is the non-oscillating period
  • a time interval (b) to (c) is the oscillating period 1
  • a time interval (a) to (c) is the intermittent oscillation period T.
  • the non-oscillating period t is infinite at a critical voltage E, higher than the starting voltage V,.
  • the critical voltage E is equal to t 1 )mur a
  • E E the higher detected voltage E results in the higher limiting current I and accordingly, in the shorter non-oscillating period t
  • the oscillating period is infinite at a voltage, which will be defined as transi tion voltage E
  • the transition voltage E is equal to
  • E E the lower detected voltage E results in the lower limiting current 1 and accordingly, in the shorter oscillating period
  • the oscillating period t tends to a finite value when the detected voltage E tends to the critical voltage E,.
  • the intermittent oscillation period T is infinite when the detected voltage E is equal to the critical voltage E, or to the transition voltage 5,.
  • the intermittent oscillation period T is insensitive to a slight change in the detected voltage E at a turnover voltage E,, near which a decrement in the I, caused by a slight increase in the E is equal to an increment in the t caused by the slight increase in the E.
  • the intermittent oscillation period T becomes longer as the detected voltage E increases.
  • the oscillator means 4 ceases the intermittent oscillation and sustains a continuous oscillation.
  • E E no oscillation occurs. Both ranges as specified by (7) and (8) make it possible to transmit an electric signal corresponding to a physiological variable.
  • a medical transmitter explained with reference to FIG. l is satisfactorily accomplished by using any available and suitable transistor tuned oscillator satisfying the relations (2) and (3).
  • a detecting means 1 comprises a positive electrode 16 and a negative electrode 17, and satisfies the relation (9).
  • the detecting means 1 is connected, at the detecting terminals 5 and 6, to a transistor tuned oscillator 4 through the limiting resistor 9 and the storing capacitor 3.
  • the storing capacitor 3 is connected between the two energizing terminals 7 and 8.
  • the limiting resistor 9 is connected between the detecting terminal 5 and the energizing terminal 7.
  • the transistor tuned oscillator 4 is a transistor Hartley oscillator which will oscillate, if a battery is connected to the two energizing terminals 7 and 8, and it consists of an NPN transistor 10, a tuning capacitor 11 having capacitance C, tuning inductors l2 and 13 having self-inductances L and L respectively, a feedback capacitor l4 having capacitance C,, and a base biasing resistor 15 having resistance R,
  • the tuning capacitor 1 l and the tuning inductors l2 and 13 act as a tuning circuit which determines the oscillation frequency f of the transistor tuned oscillator 4.
  • an inductance ratio L /L is designed to be at least 1, which is larger than the ratio appearing in a conventional transistor Hartley oscillator.
  • the transistor tuned oscillator 4 While the transistor tuned oscillator 4 is not in oscillation, a small dc current corresponding to the leakage be charged up so that an energizing voltage V gradually rises up, because the resistance R of the limiting resistor 9 is determined to enable supplying a limiting current I much larger than the leakage current I, With the rise of the energizing voltage, the leakage current 1 may increase, and an amplification factor of the transistor 10 may also increase.
  • the amplification factor of the transistor 10 grows so large that the transistor tuned oscillator 43 is made to oscillate.
  • a dc current component flowing to the transistor 10 turns into the actuating current 1,, and is much larger than the leakage current 1,, because of a non-linearity of an emittenbase characteristic of the transistor 10.
  • a charge stored in the storing capacitor 3 is discharged through the transistor tuned oscillator 4, because the resistance R, of the limiting resistor 9 is determined to supply a limiting current I much smaller than the actuating current I,
  • the energizing voltage V gradually lowers while the actuating current 1,, is decreasing.
  • the transistor tuned oscillator 4 stops the oscillation and turns into the initial state where only a slight current corresponding to the leakage current 1 flows into the transistor tuned oscillator 4.
  • the medical transmitter of FIG. 5 generates the intermittent oscillation.
  • the operation of the medical transmitter of HG. 5 will be more apparent by referring to FlG. 6.
  • the energizing voltage V fluctuates between V, and V, as shown in FIG. 6 (a), and the limiting current I fluctuates between (I),,,,,,, and (1),, as shown in FIG. 6 (b).
  • the current flowing to the transistor tuned oscillator 4 changes over a wide range and its waveform has two jumps at the beginning and the end oscillation as shown in FIG. 6 (c), where the ordinate is sealed in logarithm.
  • a voltage A between the collector and the emitter of the transistor 10 changes as shown in FIG. 6 (d), and a voltage B across the tuning capacitor ill changes as shown in FIG. 6 (e).
  • a medical transmitter having E, of 0.5 volts and E, of 2.0 volts can be formed by using components listed in Table l and its main'performance indices actually measured are shown in Table 2.
  • the t t and T versus the E relations of the medical transmitter are shown in FIG. 4.
  • a transistor tuned oscillator defined herein is not limited to the Hartley oscillator, but any other transistor tuned oscillator such as a Colpitts or other tuned-collector oscillator is essentially satisfactory.
  • the transistor tuned oscillator 4 shown in F IG. 5 has a tuning capacitor 11 intentionally inserted therein.
  • a tuning circuit having no tuning capacitor inserted therein For example, one may use a tuning circuit consisting of the tuning inductors l2 and 13, a stray capacitance in the tuning inductors l2 and ll3 and others, and an electrode to electrode capacitance of the transistor T0.
  • a pH sensor of the aforesaid detecting means 1 in any of FIGS. 1, 2 and 5 achieves a medical transmitter adapted for transmission of an electrical signal corresponding to a pH value in a gastro-intestinal tract.
  • the pH sensor for use in the detecting means 1 is preferably provided with a detected voltage within a range between 0.5 and 2.0 volts.
  • the pH sensor usually comprises two electrodes, i.e. one is a pH sensitive electrode and the other is a reference electrode as is well-known.
  • the operable pH sensor as the detecting means 1 shown in FIG. 5 comprises, as a pH sensitive electrode, a member selected from the group consisting of an antimony electrode, a
  • the medical transmitter using this pH sensor has a rather high sensitivity for high pH values and therefore is suitable for measurement of the pH value in intestines.
  • a pH sensor suitable for measurement in the stomach comprises, as a pH sensitive electrode, a member selected from the group consisting of a antimony electrode, a molybdenum electrode, a tungsten electrode, a germanium electrode and a silicon electrode, and as a reference electrode, a member selected from the group consisting of a vanadium pentoxide electrode, a nickel sesquioxide electrode, a manganese dioxide electrode and a lead dioxide electrode.
  • the medical transmitter using such a pH sensor is characterized by a rather high sensitivity for low pH values.
  • a combination of an antimony electrode and a zinc electrodev has the most stable relation between the pH value and the detected voltage.
  • an antimony electrode generates an electromotive force of about 0. l 5 volts and of about -0.45volts in a solution having pH2 and a solution having pH8, respectively.
  • the electromotive force referred to herein is measured as a reference to that of a saturated caromel electrode.
  • the electromotive force of the antimony electrode varies by about 0.05 volts per unit pH in the range of pH2 to pI-I8 which covers pH values in the gastro-intestinal tract.
  • the electromotive force of the zinc electrode shows little change with pH and is about 1.1 volts in the range of ph2 to pH8.
  • a pH sensor consisting of the antimony electrode and the zinc electrode generates detected voltages E of 0.95 volts and 0.65 volts at pH2 and pI-I8, respectively.
  • the detected voltage E varies by about 0.05 volts per unit pH in the pH range to 2 to 8.
  • a reference electrode consisting of an element selected from the group of a zinc electrode, a magnesium electrode, a manganese electrode and a zinc-magnesium alloy electrode has a negative voltage with respect to the pH sensitive electrode mentioned above. Therefore, a reference electrode consisting of such a metal electrode should be connected to the terminal 6 when the transistor 10 is NPN type, and should be connected to the terminal 5 when the transistor 10 is PNP type.
  • a reference electrode consisting of an element selected from the group of a vanadium pentoxide electrode, a nickel sesquioxide electrode, a manganese dioxide electrode and a lead dioxide electrode has a positive voltage with respect to the pH sensitive electrode mentioned above. Therefore, a reference electrode consisting of such a metal oxide electrode should be connected to the terminal 5 when the transistor 10 is NPN type, and should be connected to the terminal 6 when the transistor 10 is PNP type.
  • the electric signal from the medical transmitter is picked up by an antenna and is amplified by a conventional high frequency amplifier.
  • the amplified signal is then, for instance, converted to an analog voltage corresponding to the intermittent oscillation period T and finally is indicated on. a meter or recorded on a chart.
  • a physiological variable in a human body can be measured wirelessly.
  • the storing capacitor 3 can employ any element adapted to store an electric charge.
  • a voltage dependent capacitor as well as a voltage independent capacitor can also be utilized for the storing capacitor 3.
  • the storing capacitor is a voltage dependent capacitor 3, and the voltage dependent capacitor can improve linearity in the charging characteristic. Accordingly, stability of the intermittent oscillation period T can be improved, especially the stability at a region of the detected voltage E near the critical voltage 5,.
  • the limiting network means 2 can also comprise voltage dependent elements.
  • the limiting network means is a voltage dependent resistor 9', and the use of the voltage dependent resistor makes it possible to control a relationship between a physiological variable and an intermittent oscillation period T.
  • the storing capacitor comprises a temperature sensitive capacitor 3" capable of compensating a temperature dependence of the intermittent oscillation period of the medical transmitter.
  • the limiting network means comprises a temperature sensitive resistor 9 capable of compensating a temperature dependence of the intermittent oscillation period of the medical transmitter.
  • the intermittent oscillation period T is shortened by a temperature rise due to a change of transistor characteristics. This shift of the intermittent oscillation period T can be reduced to a negligibly small value by use of a storing capacitor or a limiting resistor characterized by a temperature coefficient of about +l0,000 ppm/C.
  • the internal resistance should be taken into account in the design of the limiting network means.
  • the medical transmitter according to the present invention can transmit another electric signal in addition to the signal resulted from the detecting means.
  • the transistor tuned oscillator 4 has a tuning capacitor 11' having a variable capacitance sensitive to an environmental condition surrounding the medical transmitter, so that the oscillation frequency varies with the environmental condition.
  • two kinds of physiological variables may be simultaneously transmitted as the functions of the intermittent oscillation period T and the oscillation frequency f.
  • the tuning capacitor 11' of FIG. 12 is a temperature sensitive capacitor
  • the oscillation frequency f changes proportionally with a temperature change of the environment around the medical transmitter.
  • the medical transmitter can transmit the electric signal concerning the temperature as well as the signal resulted from the detecting means.
  • the transistor turned oscillator 4 has a tuning inductor 12' and/or 13 having a variable inductance sensitive to a second physiological variable, so that the oscillation frequency f varies as a function of the second physiological variable.
  • a medical transmitter according to the present invention can measure a physiological variable of a human body without using a battery or the like and an external energy sender.
  • a medical transmitter adapted for transmission of an electric signal corresponding to a physiological variable in a human body, which comprises detecting means having two detecting terminals provided with a detected voltage E relating to said physiological variable; limiting network means which has two input terminals connected with said two detecting terminals and which has two output terminals provided with a limiting current I therefrom; a storing capacitor of a capacitance, C which is connected with said two output terminals; and oscillator means which has two energizing terminals connected with two terminals of said storing capacitor and energizable by an electric charge stored in said storing capacitor which functions as a power source for said oscillator means, said oscillator means for starting oscillation in an oscillation frequency f when a voltage between said two energizing terminals rises up to a starting voltage V, and for stopping said oscillation when said voltage between said two energizing terminals falls down to a stopping voltage V,, and said oscillator means having a leakage current 1, adapted to flow
  • tuning capacitor is a temperature sensitive capacitor.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physiology (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

A miniature medical transmitter detects a physiological variable in a human body and transmits a signal to a receiver placed at the outside of a human body, more particularly to an orally swallawable minature transmitter for measuring pH value or any other variable in a gastro-intestinal tract. The transmitter comprises detecting means for generating a voltage relating to a physiological variable in a human body, limiting network means, a storing capacitor and oscillator means, and its operation is based on an arrangement wherein the voltage from the detecting means activates the oscillator means and, at the same time, modulates the oscillator means. Accordingly, the transmitter does not require conventional power supply means such as battery means and external energy sender means placed outside the body.

Description

unueu marr- Murata [54] PHYSIOLOGICAL SIGNAL TRANSMITTER FOR USE INSIDE THE BODY Inventor:
Norio Murata, Hirakata-shi, Japan Matsushita Electric Industrial G. Ltd., Kadoma, Osaka, Japan Oct. 16, 1969 Assignee:
Filed:
Appl. No.:
US. Cl. ..l28/2 P, 331/66, 331/173, 340/248 Int. Cl. ..A6lf 5/00 Field of Search ....l28/2 R, 2.1 A, 2.1 P, 2.06 R, 128/419 R, 419 P, 2.1 R; 204/195; 325/118; 340/248 P, 253 P; 331/65, 66, 173
[56] References Cited UNITED STATES PATENTS 11/1965 Honig ..l28/2.1P l/l966 Watanabe ..128/2.1P
OTHER PUBLICATIONS Mackay et a1. Nature," Vol. 179, June 15, 1957 pp.
Nagumo et a]. IRE Transactions on Bio-Medical Electronics Vol. BME- 9, July, 1962, pp. 195- 199 Primary Examiner-William E. Kamm Attorney-Wenderoth, Lind & Ponack 57 sc'r A miniature medical transmitter detects a physiological variable in a human body and transmits a signal to a receiver placed at the outside of a human body, more particularly to an orally swallawable minature transmitter for measuring pH value or any other variable in a gastro-intestinal tract. The transmitter comprises detecting means for generating a voltage relating to a physiological variable in a human body, limiting network means, a storing capacitor and oscillator means, and its operation is based on an arrangement wherein the voltage from the detecting means ac;
til/ates the oscillator means and, at the same time, modulates the oscillator means. Accordingly, the transmitter does not require conventional power supply means such as battery means and external energy sender means placed outside the body.
17 Claims, 17 Drawing mes fl T M 1 l POSITIVE 5 9 7 i ELECTRODEWf I l I r 17 5 3 l 15 NEGATIVE I W W i ELEcTRooE f-GT 'L 8 s 4 T T l PATENTEBMIB m 3.682.160
SHEET 1 0F 5 5 5 I 7, l LQRIG 7 2 Q 1 g 7 K DETECTING 1 LIM'TING l OSCILLATO MEANS NETWORK MEANS R MEANS 6/ j 8I/ 8 6 a 4 FIG.|
DETECTI N6 3 OSCILLATOR MEANS MEANS FIGZ m 1 N) g I l I S i 1 1 TIME INVENTOR NORIO MURATA BY wmwww ATTORNEYS PMENTEmus' 1972 3.682.160
SHEET 3 OF 5 F|G.6o.
I FlG.6b
LOGIQ Fl(5.6c L061! TIME I B FlG.6e -lmm Mr W TIME INVENTOR NORIO MURATA BY /g// 6/ 4 PATENTEDMJB 8M2 3.682.160
SHEET 6F 5 DETEC'HNG UM] T|N G OSCILLATOR MEANS NETWORK MEANS MEANS I T 2 VOLTAGE 4 DEPENDENT Fl 6 3 CAPACITOR VOLTAGE DEPENDENT 5 QESISTOR 7/ 71/ 7 DETECTING 3 OSCILLATOR) MEANS MEANS l DETE NG .K 'Q Q OSCILLATOR MEANS MEANS MEANS TEMPERATURE SENSITIVE CAPACITOR PATENTEDIIUB 8 I972 SHEET S [If 5 TEMPERATURE SEN SITIVE ENTAL MEANS CAPACITOR SENSITIVE OSCILLATOR f RESISTOR 8 8 8 4 FIGJI I I3 I I TO AN ENVIROM A I CONDITION l I I 8 l DETECTING MEANS DETEC'ITNG MEANS FIG/I2 INOUETORS SENSITIVE TO A SECOND PHYSIOLOGICAL VARIABLE DETECTING MEANS FIGJ3 PHYSIOLOGICAL SIGNAL TRANSMITTER FOR USE INSIDE THE BODY BACKGROUND OF THE INVENTION This invention relates to a miniature medical transmitter for detecting a physiological variable in a human body and for transmitting a signal to a receiver placed at the outside of a human body, more particularly to an orally swallowable miniature transmitter for measuring pH value or any other variable in a gastro-intestinal tract.
The physiological variables in human body such as pH value and pressure in the stomach have been heretofore measured by using a stomach tube which is swallowed by patients. Besides being painful, the stomach tube makes it difficult to measure the pH value or pressure in the intestine. Recently, such disadvantages have been successfully improved by using radio telemetering capsules. They have provided useful information for research in the medical field. For instance, a broad review on these devices can be obtained by the following literatures.
l. Mackay: Radiotelemetering from within the Human Body.
IRE Transactions on Medical Electronics, Vol. ME-6, No. 2,pp. 100-105,June 1959.
2. Nagumo et a1.: Echo Capsule for Medical Use (A Batteryless Endoradiosonde).
IRE, Transactions on Bio-Medical Electronics, Vol. BME-9, No.3, pp. 195-199, July 1962.
3. U.S Pat. No. 3,133,537, Muth, May 19, 1964 The conventional devices for measuring a physiological variable in a human body wirelessly are activated by a battery or the like included therein or by energy supplied from the outside wirelessly. The use of battery or the like is apt to make the device larger and more complicated. A device activated by energy supplied from the outside needs an external energy sender and is usually operated in a shielded room for the operation.
Accordingly, it is an object of the invention to provide a medical transmitter which is capable of measuring a physiological variable of a human body without using a conventional battery or the like as an integral part of the medical transmitter.
It is another object of the invention to provide a medical transmitter which is capable of measuring a physiological variable of a human body without using an external energy sender placed outside the body in order to activate the medical transmitter.
These and other objects of this invention will be apparent upon consideration of following detailed description taken in conjunction with the accompanying drawings, wherein:
FIG. 1 is a block diagram illustrative of the medical transmitter for measuring a physiological variable in a human body in accordance with the present invention,
FIG. 2 is an embodiment of the medical transmitter according to FIG. 1,
FIG. 3 is a voltage waveform in the medical transmitter according to FIG. 2,
FIG. 4 is a graph showing the relationship between a voltage due to a physiological variable and various time intervals produced bythe medical transmitter according to FIG. 2,
FIG. 5 is one embodiment of a preferable circuit diagram of the medical transmitter according to the present invention,
FIG. 6 is a series of waveforms generated by the medical transmitter of FIG. 5,
FIG. 7 is a graph showing the relationship between pH and electromotiveforce (EMF) of an antimony electrode with reference to a saturated-calomel electrode, and FIGS. 8-13 illustrate modified embodiments of the medical transmitter according to the present invention.
A medical transmitter according to the present invention comprises detecting means for generating a voltage relating to a physiological variable in a human body, limiting network means, a storing capacitor and oscillator means, and its operation is based on the novel arrangement wherein the voltage from the detecting means activates the oscillator means and, at the same time, modulates the oscillator means.
Referring now to FIG. 1, the medical transmitter adapted for transmission of an electric signal corresponding to a physiological variable in a human body, in accordance with the present invention, comprises detecting means ll having two detecting terminals 5 and 6 provided with detected voltage E relating to the physiological variable; limiting network means 2 which has two input terminals 5' and 6 connected with the two detecting terminals 5 and 6 and which has two output terminals 7 and 8' provided with a limiting current, I therefrom; a storing capacitor 3 of a capacitance, C,,, which is connected at two terminals 7" and 8", with the two output terminals 7 and 8'; and oscillator means 4 which has two energizing terminals 7 and 8 connected with the two terminals 7" and 8" of the storing capacitor 3 and which contains no battery or the like. The oscillator means 4 starts to generate an oscillation in an oscillation frequency, f, when a voltage between the two energizing terminals 7 and 8 rises up to a starting voltage V and the oscillator means 1 stops the oscillation when the voltage between the two energizing terminals 7 and 8 falls down to a stopping voltage, V,,. The oscillator means 4 has a leakage current I to flow therethrough upon the cease of the oscillation and an actuating current I to flow therethrough during the oscillation, whereby the following relation holds:
1)ma.r )mtn )ma.r a)mtn a)ma.r a
p) (1) where (I ,is a maximum value of the leakage current 1 (I),,,,,, and D are a minimum value and a maximum value of the limiting current 1, respectively, and (l ,,l are a minimum value and a maximum value of the actuating current I respectively.
I 3 l)mrl.r u)mln can accomplish a medical transmitter satisfying the relation (1) by controlling the detected voltage E and the limiting network means 2. The medical transmitter satisfying the relation (1) always operates in an intermittent oscillation. When the oscillator means 4 supplied with an energizing voltage V lower than the starting voltage V,is not oscillating, a limiting current I is larger than a leakage current 1,. Accordingly, the storing capacitor 3 continues to be charged by a current due to a difference between a limiting current I and a leakage current I until an energizing voltage V rises up to the starting voltage V, and then an oscillation takes place in the oscillator means 4.
When the oscillator means 4 supplied with an energizing voltage V higher than the stopping voltage V is oscillating, an actuating current 1,, is larger than a limiting current 1. Accordingly, the storing capacitor 3 continues to discharge a charge stored in the storing capacitor 3 at a current due to a difference between an actuating current 1., and a limiting current 1 until an energizing voltage V falls down to the stopping voltage V,, and then the oscillation ceases.
The relation, (I,,),,,,, C,,-f-( V,V,,), which is derivedfrom the relation (1) makes it possible for the oscillator means 4 to repeat many cycles of the oscillation having oscillation frequency f during a time interval when the oscillator means 4 is oscillating. Therefore, the medical transmitter according to the present invention always operates in an intermittent oscillation.
For convenience, a time interval when the oscillator means 4 is not in oscillation and a time interval when the oscillator means 4 is oscillating will be defined as a non-oscillating period t, and an oscillating period It respectively. A time interval which is the sum of the non-oscillating period t and the oscillating period will be defined as an intermittent oscillation period, T.
A non-oscillating period t and an oscillating period t are a function of the limiting current I which is a function of the detected voltage E. Therefore, the intermittent oscillation period T of the medical transmitter is also clearly a function of the detected voltage E. Accordingly, the medical transmitter according to the present invention transmits, an electric signal corresponding to a physiological variable in a human body.
In order to transmit an electric signal corresponding exactly to a physiological variable, the intermittent oscillation period T of the medical transmitter is required to be much shorter than a time interval corresponding to one cycle of the highest frequency in a physiological variable. The use of an oscillation frequency f of medium frequency or more can easily satisfy this requirement, because the highest frequency of a physiological variable is usually not more than about lOOI-Iz.
Referring to FIG. 2, in which the limiting network means 2 consists of a limiting resistor 9 having resistance R the relation l is reduced to In the medical transmitter satisfying the above relations (4) and (5), an energizing voltage V has, for example, a waveform as shown in FIG. 3. In this figure, a time interval (a) to (b) is the non-oscillating period a time interval (b) to (c) is the oscillating period 1 a time interval (a) to (c) is the intermittent oscillation period T.
Referring to FIG. 4, the non-oscillating period t, is infinite at a critical voltage E, higher than the starting voltage V,. When the leakage current 1 increases with an increase in the energizing voltage V, the critical voltage E, is equal to t 1 )mur a When E E,, the higher detected voltage E results in the higher limiting current I and accordingly, in the shorter non-oscillating period t The oscillating period is infinite at a voltage, which will be defined as transi tion voltage E When the actuating current 1,, decreases with a decrease in the energizing voltage V, the transition voltage E, is equal to When E E the lower detected voltage E results in the lower limiting current 1 and accordingly, in the shorter oscillating period Finally, the oscillating period t tends to a finite value when the detected voltage E tends to the critical voltage E,.
As a result, the intermittent oscillation period T is infinite when the detected voltage E is equal to the critical voltage E, or to the transition voltage 5,. Referring again to FIG. 4, the intermittent oscillation period T is insensitive to a slight change in the detected voltage E at a turnover voltage E,, near which a decrement in the I, caused by a slight increase in the E is equal to an increment in the t caused by the slight increase in the E. When a detected voltage E is within the range,
EZ E EI (1) the intermittent oscillation period T becomes shorter as the detected voltage E increases. When a detected voltage E is within the range,
1 (8) the intermittent oscillation period T becomes longer as the detected voltage E increases. For E E the oscillator means 4 ceases the intermittent oscillation and sustains a continuous oscillation. For E E,, no oscillation occurs. Both ranges as specified by (7) and (8) make it possible to transmit an electric signal corresponding to a physiological variable.
( ll)llllll 0m;
A medical transmitter explained with reference to FIG. l is satisfactorily accomplished by using any available and suitable transistor tuned oscillator satisfying the relations (2) and (3). When the transistor tuned oscillator is employed for the medical transmitter having a diagram shown by FIG. 2, an arrangement for E,= 0.5 volts and E 2.0 volts satisfies a combination of a higher stability of the T and a wider measurable range, and makes it possible to measure stably a detected voltage E satisfying the following relation in accordance with the present invention.
0.5 volts E 2.0 volts 9 Referring to FIG. 5, wherein similar references designate the components similar to those of FIG. 1 and FIG. 2, a detecting means 1 comprises a positive electrode 16 and a negative electrode 17, and satisfies the relation (9). The detecting means 1 is connected, at the detecting terminals 5 and 6, to a transistor tuned oscillator 4 through the limiting resistor 9 and the storing capacitor 3. The storing capacitor 3 is connected between the two energizing terminals 7 and 8. The limiting resistor 9 is connected between the detecting terminal 5 and the energizing terminal 7.
The transistor tuned oscillator 4 is a transistor Hartley oscillator which will oscillate, if a battery is connected to the two energizing terminals 7 and 8, and it consists of an NPN transistor 10, a tuning capacitor 11 having capacitance C, tuning inductors l2 and 13 having self-inductances L and L respectively, a feedback capacitor l4 having capacitance C,, and a base biasing resistor 15 having resistance R,, The tuning capacitor 1 l and the tuning inductors l2 and 13 act as a tuning circuit which determines the oscillation frequency f of the transistor tuned oscillator 4.-
In order to make it possible to satisfy the relation (8)" and (3), an inductance ratio L /L is designed to be at least 1, which is larger than the ratio appearing in a conventional transistor Hartley oscillator.
While the transistor tuned oscillator 4 is not in oscillation, a small dc current corresponding to the leakage be charged up so that an energizing voltage V gradually rises up, because the resistance R of the limiting resistor 9 is determined to enable supplying a limiting current I much larger than the leakage current I, With the rise of the energizing voltage, the leakage current 1 may increase, and an amplification factor of the transistor 10 may also increase.
When the energizing voltage V reaches the starting voltage V,, the amplification factor of the transistor 10 grows so large that the transistor tuned oscillator 43 is made to oscillate. When once the oscillation occurs, a dc current component flowing to the transistor 10 turns into the actuating current 1,, and is much larger than the leakage current 1,, because of a non-linearity of an emittenbase characteristic of the transistor 10. Then a charge stored in the storing capacitor 3 is discharged through the transistor tuned oscillator 4, because the resistance R, of the limiting resistor 9 is determined to supply a limiting current I much smaller than the actuating current I,, The energizing voltage V gradually lowers while the actuating current 1,, is decreasing.
When the energizing voltage V falls down to the stopping voltage V,,, the amplification factor becomes so small that the transistor tuned oscillator 4 is unable to sustain the oscillation. Thus the transistor tuned oscillator 4 stops the oscillation and turns into the initial state where only a slight current corresponding to the leakage current 1 flows into the transistor tuned oscillator 4.
With such a process the medical transmitter of FIG. 5 generates the intermittent oscillation.
The operation of the medical transmitter of HG. 5 will be more apparent by referring to FlG. 6. The energizing voltage V fluctuates between V, and V, as shown in FIG. 6 (a), and the limiting current I fluctuates between (I),,,,,, and (1),, as shown in FIG. 6 (b). The current flowing to the transistor tuned oscillator 4 changes over a wide range and its waveform has two jumps at the beginning and the end oscillation as shown in FIG. 6 (c), where the ordinate is sealed in logarithm. A voltage A between the collector and the emitter of the transistor 10 changes as shown in FIG. 6 (d), and a voltage B across the tuning capacitor ill changes as shown in FIG. 6 (e).
As an example, a medical transmitter having E, of 0.5 volts and E, of 2.0 volts can be formed by using components listed in Table l and its main'performance indices actually measured are shown in Table 2. The t t and T versus the E relations of the medical transmitter are shown in FIG. 4.
It should be understood that a transistor tuned oscillator defined herein is not limited to the Hartley oscillator, but any other transistor tuned oscillator such as a Colpitts or other tuned-collector oscillator is essentially satisfactory.
The transistor tuned oscillator 4 shown in F IG. 5 has a tuning capacitor 11 intentionally inserted therein. However, it is also possible to utilize a tuning circuit having no tuning capacitor inserted therein. For example, one may use a tuning circuit consisting of the tuning inductors l2 and 13, a stray capacitance in the tuning inductors l2 and ll3 and others, and an electrode to electrode capacitance of the transistor T0.
TABLE 1 limiting resistor, 9 (R 100 kfl storing capacitor, 3 (C,,) 0.22 p.F transistor, 10 2SC829 tuning capacitor, 11 (C) 2 pF inductance ratio (L /L,) l6 0 value of the tuning coil feedback capacitor, 14 (C,,) 560 pF base biasing resistor, 15 (R,,) 50 kfl oscillation frequency (f) 2 MHz TABLE 2 starting voltage, V, 0.467 V stopping voltage, V, 0.194 V maximum value of the (I,),,,,,,. 0.3 #A leakage current,
minimum value of the (I,,),,,,,, 22 p.A actuating current, maximum value of the (I,,),,,,,,. 480 A actuating current, critical voltage, E, 0.499 V transition voltage, E, 2.35 V turnover voltage, E, 2.08 V
The employment of a pH sensor of the aforesaid detecting means 1 in any of FIGS. 1, 2 and 5 achieves a medical transmitter adapted for transmission of an electrical signal corresponding to a pH value in a gastro-intestinal tract. When the transmitter explained with reference to FIG. is used for measurement of the pH value, the pH sensor for use in the detecting means 1 is preferably provided with a detected voltage within a range between 0.5 and 2.0 volts.
The pH sensor usually comprises two electrodes, i.e. one is a pH sensitive electrode and the other is a reference electrode as is well-known. The operable pH sensor as the detecting means 1 shown in FIG. 5 comprises, as a pH sensitive electrode, a member selected from the group consisting of an antimony electrode, a
' molybdenum electrode, a tungsten electrode, a germanium electrode and a silicon electrode, and as a reference electrode, a member selected from the group consisting of a zinc electrode, a manganese electrode, a mangesium electrode, and a zinc-magnesium alloy electrode. The medical transmitter using this pH sensor has a rather high sensitivity for high pH values and therefore is suitable for measurement of the pH value in intestines.
On the other hand, a pH sensor suitable for measurement in the stomach comprises, as a pH sensitive electrode, a member selected from the group consisting of a antimony electrode, a molybdenum electrode, a tungsten electrode, a germanium electrode and a silicon electrode, and as a reference electrode, a member selected from the group consisting of a vanadium pentoxide electrode, a nickel sesquioxide electrode, a manganese dioxide electrode and a lead dioxide electrode. The medical transmitter using such a pH sensor is characterized by a rather high sensitivity for low pH values.
Among those operable pH sensors, a combination of an antimony electrode and a zinc electrodev has the most stable relation between the pH value and the detected voltage.
Referring to FIG. 7, an antimony electrode generates an electromotive force of about 0. l 5 volts and of about -0.45volts in a solution having pH2 and a solution having pH8, respectively. The electromotive force referred to herein is measured as a reference to that of a saturated caromel electrode. The electromotive force of the antimony electrode varies by about 0.05 volts per unit pH in the range of pH2 to pI-I8 which covers pH values in the gastro-intestinal tract.
On the other hand, the electromotive force of the zinc electrode shows little change with pH and is about 1.1 volts in the range of ph2 to pH8.
Accordingly, a pH sensor consisting of the antimony electrode and the zinc electrode generates detected voltages E of 0.95 volts and 0.65 volts at pH2 and pI-I8, respectively. The detected voltage E varies by about 0.05 volts per unit pH in the pH range to 2 to 8.
A reference electrode consisting of an element selected from the group of a zinc electrode, a magnesium electrode, a manganese electrode and a zinc-magnesium alloy electrode has a negative voltage with respect to the pH sensitive electrode mentioned above. Therefore, a reference electrode consisting of such a metal electrode should be connected to the terminal 6 when the transistor 10 is NPN type, and should be connected to the terminal 5 when the transistor 10 is PNP type.
On the contrary, a reference electrode consisting of an element selected from the group of a vanadium pentoxide electrode, a nickel sesquioxide electrode, a manganese dioxide electrode and a lead dioxide electrode has a positive voltage with respect to the pH sensitive electrode mentioned above. Therefore, a reference electrode consisting of such a metal oxide electrode should be connected to the terminal 5 when the transistor 10 is NPN type, and should be connected to the terminal 6 when the transistor 10 is PNP type.
The electric signal from the medical transmitter is picked up by an antenna and is amplified by a conventional high frequency amplifier. The amplified signal is then, for instance, converted to an analog voltage corresponding to the intermittent oscillation period T and finally is indicated on. a meter or recorded on a chart. As a result, a physiological variable in a human body can be measured wirelessly.
In general, the storing capacitor 3 can employ any element adapted to store an electric charge. Thus, for example, a voltage dependent capacitor as well as a voltage independent capacitor can also be utilized for the storing capacitor 3. Referring to FIG. 8, the storing capacitor is a voltage dependent capacitor 3, and the voltage dependent capacitor can improve linearity in the charging characteristic. Accordingly, stability of the intermittent oscillation period T can be improved, especially the stability at a region of the detected voltage E near the critical voltage 5,.
The limiting network means 2 can also comprise voltage dependent elements. Referring to FIG. 9, the limiting network means is a voltage dependent resistor 9', and the use of the voltage dependent resistor makes it possible to control a relationship between a physiological variable and an intermittent oscillation period T.
An undesirable temperature dependence of the intermittent oscillation period T, if it exists, can be compensated by use of a storing capacitor comprising a temperature sensitive capacitor and/or by use of limiting network means comprising temperature sensitive elements. Referring to FIG. 10, the storing capacitor comprises a temperature sensitive capacitor 3" capable of compensating a temperature dependence of the intermittent oscillation period of the medical transmitter. Referring to FIG. ill, the limiting network means comprises a temperature sensitive resistor 9 capable of compensating a temperature dependence of the intermittent oscillation period of the medical transmitter. In the medical transmitter as specified by Table l, for example, the intermittent oscillation period T is shortened by a temperature rise due to a change of transistor characteristics. This shift of the intermittent oscillation period T can be reduced to a negligibly small value by use of a storing capacitor or a limiting resistor characterized by a temperature coefficient of about +l0,000 ppm/C.
When the detecting means 1 has a considerable internal resistance, the internal resistance should be taken into account in the design of the limiting network means.
The medical transmitter according to the present invention can transmit another electric signal in addition to the signal resulted from the detecting means. Referring to FIG. 12, the transistor tuned oscillator 4 has a tuning capacitor 11' having a variable capacitance sensitive to an environmental condition surrounding the medical transmitter, so that the oscillation frequency varies with the environmental condition. As a result, two kinds of physiological variables may be simultaneously transmitted as the functions of the intermittent oscillation period T and the oscillation frequency f.
When the tuning capacitor 11' of FIG. 12 is a temperature sensitive capacitor, the oscillation frequency f changes proportionally with a temperature change of the environment around the medical transmitter. Thus, the medical transmitter can transmit the electric signal concerning the temperature as well as the signal resulted from the detecting means.
Referring to FIG. 13, the transistor turned oscillator 4 has a tuning inductor 12' and/or 13 having a variable inductance sensitive to a second physiological variable, so that the oscillation frequency f varies as a function of the second physiological variable.
In the medical transmitter as shown in FIG. 13, use of the tuning inductors 12' and 13 having a movable magnetic core with a pressure in the environment surrounding the medical transmitter, causes the inductances of the tuning inductors l2 and 13' to change with the pressure which is a second physiological variable. Thus, the oscillation frequency f changes in accordance with the pressure change.
It is readily apparent that a medical transmitter according to the present invention can measure a physiological variable of a human body without using a battery or the like and an external energy sender.
While certain representative embodiments and details have been shown by the purpose of illustrating the invention, it will be apparent to those skilled in the art that various changes and modifications may be made therein without departing from the spirit or scope of invention.
What is claimed is:
l. A medical transmitter adapted for transmission of an electric signal corresponding to a physiological variable in a human body, which comprises detecting means having two detecting terminals provided with a detected voltage E relating to said physiological variable; limiting network means which has two input terminals connected with said two detecting terminals and which has two output terminals provided with a limiting current I therefrom; a storing capacitor of a capacitance, C which is connected with said two output terminals; and oscillator means which has two energizing terminals connected with two terminals of said storing capacitor and energizable by an electric charge stored in said storing capacitor which functions as a power source for said oscillator means, said oscillator means for starting oscillation in an oscillation frequency f when a voltage between said two energizing terminals rises up to a starting voltage V, and for stopping said oscillation when said voltage between said two energizing terminals falls down to a stopping voltage V,,, and said oscillator means having a leakage current 1, adapted to flow therethrough upon the cessation of said oscillation and an actuating current I. to flow therethrough during oscillation, said oscillating means having the following operating characteristic:
l)mn.r )I|l||l )nm.r |l a)ma.r 0-
in P) where (1 is a maximum value of said leakage current 1,, (I),,,,,, and (1) are a minimum value and a maximum value of said limiting current 1, respectively, and (l and (I,,),,,,,, are a minimum value and a maximum value of said actuating current 1 respectively; whereby said oscillator means is intermittently oscillating with an intermittent oscillation period which is variable with a change in said detected voltage.
2. A medical transmitter defined by claim 23, wherein said limiting network means comprises a limiting resistor having resistance R 3. A medical transmitter defined by claim 2, wherein said oscillator means comprises a transistor tuned oscillator.
. 4. A medical transmitter defined by claim 3, wherein said detecting means comprises a pH sensor.
5. A medical transmitter defined by claim 4, wherein said pH sensor has a pH sensitive electrode comprising an antimony electrode, and a reference electrode comprising a zinc electrode.
6. A medical transmitter defined by claim 4, wherein said pI-I sensor has a pH sensitive electrode comprising an antimony electrode, and a reference electrode comprising a manganese electrode. 1
7. A medical transmitter as claimed in claim 4, wherein said pH sensor has a pH sensitive electrode comprising an antimony electrode, and a reference electrode .comprising a magnesium-zinc alloy electrode.
8. A medical transmitter asclaimed in claim 4, wherein said pH sensor has a pH sensitive electrode comprising an antimony electrode, and a reference electrode comprising a manganese dioxide electrode.
9. A medical transmitter as claimed in claim 4, wherein said pH sensor has a pH sensitive electrode comprising an antimony electrode and a reference electrode comprising a vanadium pentoxide electrode.
10. A medical transmitter defined by claim 3, wherein said transistor tuned oscillator has a tuning capacitor having a variable capacitance sensitive to an enviromental condition surrounding said medical transmitter. v
11.- A medical transmitter defined by claim 10, wherein said tuning capacitor is a temperature sensitive capacitor.
12. A medical transmitter defined by claim 3, wherein said transistor tuned oscillator has a tuning inductor, an inductance of which is variable depending upon a second physiological.
13. A medical transmitter defined by claim 12, wherein said second physiological variable is pressure and said tuning inductor has a magnetic core movable with a change in said pressure.
14. A medical transmitter defined by claim 1, wherein said storing capacitor is a voltage dependent capacitor.
15. A medical transmitter defined by claim 1, wherein said limiting network means comprises voltage dependent elements.
16. A medical transmitter defined by claim 1, wherein said storing capacitor consists essentially of a temperature sensitive capacitor capable of compensating a temperature dependence of said intermittent oscillation period of said medical transmitter.
17. A medical transmitter defined by claim 1, wherein said limiting network means comprises temperature sensitive elements capable of compensating a tion period of said medical transmitter.

Claims (17)

1. A medical transmitter adapted for transmission of an electric signal corresponding to a physiological variable in a human body, which comprises detecting means having two detecting terminals provided with a detected voltage E relating to said physiological variable; limiting network means which has two input terminals connected with said two detecting terminals and which has two output terminals provided with a limiting current I therefrom; a storing capacitor of a capacitance, Co, which is connected with said two output terminals; and oscillator means which has two energizing terminals connected with two terminals of said storing capacitor and energizable by an electric charge stored in said storing capacitor which functions as a power source for said oscillator means, said oscillator means for starting oscillation in an oscillation frequency f when a voltage between said two energizing terminals rises up to a starting voltage Vt and for stopping said oscillation when said voltage between said two energizing terminals falls down to a stopping voltage Vp, and said oscillator means having a leakage current I1 adapted to flow therethrough upon the cessation of said oscillation and an actuating current Ia to flow therethrough during oscillation, said oscillating means having the following operating characteristic: 0 < (I1)max < (I)min < (I)max < (Ia< (Ia)max << Co.f.(Vt-Vp) where (I1)max is a maximum value of said leakage current I1, (I)min and (I)max are a minimum value and a maximum value of said limiting current I, respectively, and (Ia)min and (Ia)max are a minimum value and a maximum value of said actuating current Ia, respectively; whereby said oscillator means is intermittently oscillating with an intermittent oscillation period which is variable with a change in said detected voltage.
2. A medical transmitter defined by claim 23, wherein said limiting network means comprises a limiting resistor having resistance Ro.
3. A medical transmitter defined by claim 2, wherein said oscillator means comprises a transistor tuned oscillator.
4. A medical transmitter defined by claim 3, wherein said detecting means comprises a pH sensor.
5. A medical transmitter defined by claim 4, wherein said pH sensor has a pH sensitive electrode comprising an antimony electrode, and a reference electrode comprising a zinc electrode.
6. A medical transmitter defined by claim 4, wherein said pH sensor has a pH sensitive electrode comprising an antimony electrode, and a reference electrode comprising a manganese electrode.
7. A medical transmitter as claimed in claim 4, wherein said pH sensor has a pH sensitive electrode comprising an antimony electrode, and a reference electrode comprising a magnesium-zinc alloy electrode.
8. A medical transmitter as claimed in claim 4, wherein said pH sensor has a pH sensitive electrode comprising an antimony electrode, and a reference electrode comprising a manganese dioxide electrode.
9. A medical transmitter as claimed in claim 4, wherein said pH sensor has a pH sensitive electrode comprising an antimony electrode and a reference electrode comprising a vanadium pentoxide electrode.
10. A medical transmitter defined by claim 3, wherein said transistor tuned oscillator has a tuning capacitor having a variable capacitance sensitive to an enviromental condition surrounding said medical transmitter.
11. A medical transmitter defined by claim 10, wherein said tuning capacitor is a temperature sensitive capacitor.
12. A medical transmitter defined by claim 3, wherein said transistor tuned oscillator has a tuning inductor, an inductance of which is variable depending upon a second physiological.
13. A medical transmitter defined by claim 12, wherein said second physiological variable is pressure and said tuning inductor has a magnetic core movable with a change in said pressure.
14. A medical transmitter defined by claim 1, wherein said storing capacitor is a voltage dependent capacitor.
15. A medical transmitter defined by claim 1, wherein said limiting network means comprises voltage dependent elements.
16. A medical transmitter defined by claim 1, wherein said storing capacitor consists essentially of a temperature sensitive capacitor capable of compensating a temperature dependence of said intermittent oscillation period of said medical transmitter.
17. A medical transmitter defined by claim 1, wherein said limiting network means comprises temperature sensitive elements capable of compensating a temperature dependence of said intermittent oscillation period of said medical transmitter.
US866818A 1969-10-16 1969-10-16 Physiological signal transmitter for use inside the body Expired - Lifetime US3682160A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86681869A 1969-10-16 1969-10-16

Publications (1)

Publication Number Publication Date
US3682160A true US3682160A (en) 1972-08-08

Family

ID=25348486

Family Applications (1)

Application Number Title Priority Date Filing Date
US866818A Expired - Lifetime US3682160A (en) 1969-10-16 1969-10-16 Physiological signal transmitter for use inside the body

Country Status (1)

Country Link
US (1) US3682160A (en)

Cited By (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3837339A (en) * 1972-02-03 1974-09-24 Whittaker Corp Blood glucose level monitoring-alarm system and method therefor
US3924251A (en) * 1974-03-25 1975-12-02 Hydril Co Input signal powered converter
US4177800A (en) * 1978-04-10 1979-12-11 Enger Carl C Implantable biotelemetry transmitter and method of using same
EP0138402A2 (en) * 1983-09-16 1985-04-24 Alfred Cuschieri A method and apparatus for monitoring pH values
US5016631A (en) * 1990-03-23 1991-05-21 The Johns Hopkins University Minimum interface biomedical monitoring system
US5415181A (en) * 1993-12-01 1995-05-16 The Johns Hopkins University AM/FM multi-channel implantable/ingestible biomedical monitoring telemetry system
WO2002026115A2 (en) * 2000-09-27 2002-04-04 Healthetech, Inc. Self-contained monitoring device particularly useful for monitoring physiological conditions
US6453199B1 (en) * 1996-04-01 2002-09-17 Valery Ivanovich Kobozev Electrical gastro-intestinal tract stimulator
US20020198470A1 (en) * 2001-06-26 2002-12-26 Imran Mir A. Capsule and method for treating or diagnosing the intestinal tract
US6653842B2 (en) * 2001-07-10 2003-11-25 Digital Concepts Of Missouri Galvanic probes as pH and oxidation reduction potential sensors, control devices employing such probes, and related methods
US20040087839A1 (en) * 1995-02-24 2004-05-06 Brigham And Women's Hospital Health monitoring system
US20040133076A1 (en) * 2002-07-23 2004-07-08 Pentax Corporation Capsule endoscope guidance system, capsule endoscope holder, and capsule endoscope
US20040183607A1 (en) * 2001-10-05 2004-09-23 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern Californ Switched reactance modulated E-class oscillator
US20040193029A1 (en) * 2003-03-27 2004-09-30 Arkady Glukhovsky Measuring a gradient in-vivo
US20050043601A1 (en) * 1999-04-07 2005-02-24 Endonetics, Inc. Implantable monitoring probe
US6864755B2 (en) 2000-10-06 2005-03-08 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Switched reactance modulated E-class oscillator design
US20050195118A1 (en) * 2004-03-08 2005-09-08 Pentax Corporation Wearable jacket having communication function, and endoscope system employing wearable jacket
US20050194012A1 (en) * 2004-03-08 2005-09-08 Pentax Corporation Wearable jacket for diagnosis and endoscope system employing wearable jacket
US20050195785A1 (en) * 2004-03-08 2005-09-08 Pentax Corporation Image signal processing device
US7013178B2 (en) 2002-09-25 2006-03-14 Medtronic, Inc. Implantable medical device communication system
US7139613B2 (en) 2002-09-25 2006-11-21 Medtronic, Inc. Implantable medical device communication system with pulsed power biasing
US7286884B2 (en) 2004-01-16 2007-10-23 Medtronic, Inc. Implantable lead including sensor
US20080284599A1 (en) * 2005-04-28 2008-11-20 Proteus Biomedical, Inc. Pharma-Informatics System
US20080302660A1 (en) * 2007-06-07 2008-12-11 Kahn Carolyn R Silicon Electrochemical Sensors
US20100121161A1 (en) * 2007-04-17 2010-05-13 Boston Scientific Scimed, Inc. Ambulatory Urodynamics
US20100277248A1 (en) * 2009-05-01 2010-11-04 Mcclain Jr Ross A Systems and methods for generating pulsed output signals using a gated RF oscillator circuit
US20100298668A1 (en) * 2008-08-13 2010-11-25 Hooman Hafezi Ingestible Circuitry
US20110295079A1 (en) * 2008-08-11 2011-12-01 Nxp B.V. Ingestible devices for measuring physiological parameters
US8114021B2 (en) 2008-12-15 2012-02-14 Proteus Biomedical, Inc. Body-associated receiver and method
US8258962B2 (en) 2008-03-05 2012-09-04 Proteus Biomedical, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US8396563B2 (en) 2010-01-29 2013-03-12 Medtronic, Inc. Clock synchronization in an implantable medical device system
US8540632B2 (en) 2007-05-24 2013-09-24 Proteus Digital Health, Inc. Low profile antenna for in body device
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
US8545402B2 (en) 2009-04-28 2013-10-01 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US8547248B2 (en) 2005-09-01 2013-10-01 Proteus Digital Health, Inc. Implantable zero-wire communications system
US8558563B2 (en) 2009-08-21 2013-10-15 Proteus Digital Health, Inc. Apparatus and method for measuring biochemical parameters
US8583227B2 (en) 2008-12-11 2013-11-12 Proteus Digital Health, Inc. Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
US8597186B2 (en) 2009-01-06 2013-12-03 Proteus Digital Health, Inc. Pharmaceutical dosages delivery system
US8718193B2 (en) 2006-11-20 2014-05-06 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US8730031B2 (en) 2005-04-28 2014-05-20 Proteus Digital Health, Inc. Communication system using an implantable device
US8758584B2 (en) 2010-12-16 2014-06-24 Sensor Innovations, Inc. Electrochemical sensors
US8784308B2 (en) 2009-12-02 2014-07-22 Proteus Digital Health, Inc. Integrated ingestible event marker system with pharmaceutical product
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8858432B2 (en) 2007-02-01 2014-10-14 Proteus Digital Health, Inc. Ingestible event marker systems
US8868453B2 (en) 2009-11-04 2014-10-21 Proteus Digital Health, Inc. System for supply chain management
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US8932221B2 (en) 2007-03-09 2015-01-13 Proteus Digital Health, Inc. In-body device having a multi-directional transmitter
US8945005B2 (en) 2006-10-25 2015-02-03 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US8956287B2 (en) 2006-05-02 2015-02-17 Proteus Digital Health, Inc. Patient customized therapeutic regimens
US8956288B2 (en) 2007-02-14 2015-02-17 Proteus Digital Health, Inc. In-body power source having high surface area electrode
US8961412B2 (en) 2007-09-25 2015-02-24 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
US9014779B2 (en) 2010-02-01 2015-04-21 Proteus Digital Health, Inc. Data gathering system
US9107806B2 (en) 2010-11-22 2015-08-18 Proteus Digital Health, Inc. Ingestible device with pharmaceutical product
US9149423B2 (en) 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US9270503B2 (en) 2013-09-20 2016-02-23 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9268909B2 (en) 2012-10-18 2016-02-23 Proteus Digital Health, Inc. Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
US9271897B2 (en) 2012-07-23 2016-03-01 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
US9439599B2 (en) 2011-03-11 2016-09-13 Proteus Digital Health, Inc. Wearable personal body associated device with various physical configurations
US9439566B2 (en) 2008-12-15 2016-09-13 Proteus Digital Health, Inc. Re-wearable wireless device
US20160338615A1 (en) * 2014-02-20 2016-11-24 Given Imaging Ltd In-vivo device using two communication modes
US9577864B2 (en) 2013-09-24 2017-02-21 Proteus Digital Health, Inc. Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
US9597487B2 (en) 2010-04-07 2017-03-21 Proteus Digital Health, Inc. Miniature ingestible device
US9603550B2 (en) 2008-07-08 2017-03-28 Proteus Digital Health, Inc. State characterization based on multi-variate data fusion techniques
US9659423B2 (en) 2008-12-15 2017-05-23 Proteus Digital Health, Inc. Personal authentication apparatus system and method
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US9883819B2 (en) 2009-01-06 2018-02-06 Proteus Digital Health, Inc. Ingestion-related biofeedback and personalized medical therapy method and system
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US10187121B2 (en) 2016-07-22 2019-01-22 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US10223905B2 (en) 2011-07-21 2019-03-05 Proteus Digital Health, Inc. Mobile device and system for detection and communication of information received from an ingestible device
US10398161B2 (en) 2014-01-21 2019-09-03 Proteus Digital Heal Th, Inc. Masticable ingestible product and communication system therefor
US10529044B2 (en) 2010-05-19 2020-01-07 Proteus Digital Health, Inc. Tracking and delivery confirmation of pharmaceutical products
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
US11149123B2 (en) 2013-01-29 2021-10-19 Otsuka Pharmaceutical Co., Ltd. Highly-swellable polymeric films and compositions comprising the same
US11158149B2 (en) 2013-03-15 2021-10-26 Otsuka Pharmaceutical Co., Ltd. Personal authentication apparatus system and method
US11167059B2 (en) 2010-04-13 2021-11-09 Kci Licensing, Inc. Compositions with reactive ingredients, and wound dressings, apparatuses, and methods
US11529071B2 (en) 2016-10-26 2022-12-20 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers
US11744481B2 (en) 2013-03-15 2023-09-05 Otsuka Pharmaceutical Co., Ltd. System, apparatus and methods for data collection and assessing outcomes

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3218638A (en) * 1962-05-29 1965-11-16 William M Honig Wireless passive biological telemetry system
US3231834A (en) * 1961-10-06 1966-01-25 Nippon Electric Co Telemetering capsule for physiological measurements

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3231834A (en) * 1961-10-06 1966-01-25 Nippon Electric Co Telemetering capsule for physiological measurements
US3218638A (en) * 1962-05-29 1965-11-16 William M Honig Wireless passive biological telemetry system

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Mackay et al. Nature, Vol. 179, June 15, 1957 pp. 1,239 1,240 *
Nagumo et al. IRE Transactions on Bio Medical Electronics Vol. BME 9, July, 1962, pp. 195 199 *

Cited By (177)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3837339A (en) * 1972-02-03 1974-09-24 Whittaker Corp Blood glucose level monitoring-alarm system and method therefor
US3924251A (en) * 1974-03-25 1975-12-02 Hydril Co Input signal powered converter
US4177800A (en) * 1978-04-10 1979-12-11 Enger Carl C Implantable biotelemetry transmitter and method of using same
EP0138402A2 (en) * 1983-09-16 1985-04-24 Alfred Cuschieri A method and apparatus for monitoring pH values
EP0138402A3 (en) * 1983-09-16 1986-04-30 Alfred Cuschieri A method and apparatus for monitoring ph values
US5016631A (en) * 1990-03-23 1991-05-21 The Johns Hopkins University Minimum interface biomedical monitoring system
US5415181A (en) * 1993-12-01 1995-05-16 The Johns Hopkins University AM/FM multi-channel implantable/ingestible biomedical monitoring telemetry system
US20040087839A1 (en) * 1995-02-24 2004-05-06 Brigham And Women's Hospital Health monitoring system
US7273454B2 (en) 1995-02-24 2007-09-25 Brigham And Women's Hospital Health monitoring system
US6453199B1 (en) * 1996-04-01 2002-09-17 Valery Ivanovich Kobozev Electrical gastro-intestinal tract stimulator
US20050043601A1 (en) * 1999-04-07 2005-02-24 Endonetics, Inc. Implantable monitoring probe
WO2002026115A2 (en) * 2000-09-27 2002-04-04 Healthetech, Inc. Self-contained monitoring device particularly useful for monitoring physiological conditions
WO2002026115A3 (en) * 2000-09-27 2002-07-04 Healthetech Inc Self-contained monitoring device particularly useful for monitoring physiological conditions
US6889087B2 (en) 2000-10-06 2005-05-03 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Switched reactance modulated E-class oscillator design
US6864755B2 (en) 2000-10-06 2005-03-08 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Switched reactance modulated E-class oscillator design
US8517961B2 (en) 2001-06-26 2013-08-27 Entrack, Inc. System for marking a location for treatment within the gastrointestinal tract
US7160258B2 (en) 2001-06-26 2007-01-09 Entrack, Inc. Capsule and method for treating or diagnosing the intestinal tract
US20110046479A1 (en) * 2001-06-26 2011-02-24 Imran Mir A System for marking a location for treatment within the gastrointestinal tract
US8915867B2 (en) 2001-06-26 2014-12-23 Entrack, Inc. System for marking a location for treatment within the gastrointestinal tract
US9167990B2 (en) 2001-06-26 2015-10-27 Entrack, Inc. Optical capsule and spectroscopic method for treating and diagnosing the intestinal tract
US20040068204A1 (en) * 2001-06-26 2004-04-08 Imran Mir A. System for marking a location for treatment within the gastrointestinal tract
US7824347B2 (en) 2001-06-26 2010-11-02 Entrack, Inc. System for marking a location for treatment within the gastrointestinal tract
US8005536B2 (en) 2001-06-26 2011-08-23 Entrack, Inc. Capsule and method for treating or diagnosing conditions or diseases of the intestinal tract
US10226608B2 (en) 2001-06-26 2019-03-12 Entrack, Inc. Optical capsule and spectroscopic method for treating and diagnosing the intestinal tract
US20020198470A1 (en) * 2001-06-26 2002-12-26 Imran Mir A. Capsule and method for treating or diagnosing the intestinal tract
US20040162501A1 (en) * 2001-06-26 2004-08-19 Imran Mir A. Capsule and method for treating or diagnosing conditions or diseases of the intestinal tract
US8360976B2 (en) 2001-06-26 2013-01-29 Entrack, Inc. Optical capsule and spectroscopic method for treating or diagnosing the intestinal tract
US20040162469A1 (en) * 2001-06-26 2004-08-19 Imran Mir A. Optical capsule and spectroscopic method for treating or diagnosing the intestinal tract
US9456774B2 (en) 2001-06-26 2016-10-04 Entrack, Inc. System for marking a location for treatment within the gastrointestinal tract
US9414768B2 (en) 2001-06-26 2016-08-16 Entrack, Inc. Capsule and method for treating or diagnosing conditions or diseases of the intestinal tract
US20040104130A1 (en) * 2001-07-10 2004-06-03 Mosley Michael David Galvanic probes as pH and oxidation reduction potential sensors, control devices employing such probes, and related methods
US6653842B2 (en) * 2001-07-10 2003-11-25 Digital Concepts Of Missouri Galvanic probes as pH and oxidation reduction potential sensors, control devices employing such probes, and related methods
US20040183607A1 (en) * 2001-10-05 2004-09-23 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern Californ Switched reactance modulated E-class oscillator
US7005935B2 (en) 2001-10-05 2006-02-28 Alfred E. Mann Institute For Biomedical Engineering At The University Of Southern California Switched reactance modulated E-class oscillator
US20040133076A1 (en) * 2002-07-23 2004-07-08 Pentax Corporation Capsule endoscope guidance system, capsule endoscope holder, and capsule endoscope
US7001329B2 (en) 2002-07-23 2006-02-21 Pentax Corporation Capsule endoscope guidance system, capsule endoscope holder, and capsule endoscope
US7139613B2 (en) 2002-09-25 2006-11-21 Medtronic, Inc. Implantable medical device communication system with pulsed power biasing
US7013178B2 (en) 2002-09-25 2006-03-14 Medtronic, Inc. Implantable medical device communication system
US7245954B2 (en) * 2003-03-27 2007-07-17 Given Imaging Ltd. Measuring a gradient in-vivo
US20040193029A1 (en) * 2003-03-27 2004-09-30 Arkady Glukhovsky Measuring a gradient in-vivo
US20080004681A1 (en) * 2004-01-16 2008-01-03 Marshall Mark T Novel implantable lead including sensor
US7286884B2 (en) 2004-01-16 2007-10-23 Medtronic, Inc. Implantable lead including sensor
US8103357B2 (en) 2004-01-16 2012-01-24 Medtronic, Inc. Implantable lead including sensor
US7109933B2 (en) 2004-03-08 2006-09-19 Pentax Corporation Wearable jacket having communication function, and endoscope system employing wearable jacket
US20050195785A1 (en) * 2004-03-08 2005-09-08 Pentax Corporation Image signal processing device
US20050194012A1 (en) * 2004-03-08 2005-09-08 Pentax Corporation Wearable jacket for diagnosis and endoscope system employing wearable jacket
US20050195118A1 (en) * 2004-03-08 2005-09-08 Pentax Corporation Wearable jacket having communication function, and endoscope system employing wearable jacket
US11044024B2 (en) 2005-04-28 2021-06-22 Proteus Digital Health, Inc. Communication system with partial power source
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US10517507B2 (en) 2005-04-28 2019-12-31 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US20080284599A1 (en) * 2005-04-28 2008-11-20 Proteus Biomedical, Inc. Pharma-Informatics System
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US10610128B2 (en) * 2005-04-28 2020-04-07 Proteus Digital Health, Inc. Pharma-informatics system
US7978064B2 (en) * 2005-04-28 2011-07-12 Proteus Biomedical, Inc. Communication system with partial power source
US20180214048A1 (en) * 2005-04-28 2018-08-02 Proteus Digital Health, Inc. Pharma-informatics system
US9962107B2 (en) 2005-04-28 2018-05-08 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
CN103259027A (en) * 2005-04-28 2013-08-21 普罗透斯数字保健公司 Pharma-informatics system
US20110105864A1 (en) * 2005-04-28 2011-05-05 Timothy Robertson Pharma-Informatics System
US9681842B2 (en) * 2005-04-28 2017-06-20 Proteus Digital Health, Inc. Pharma-informatics system
US9649066B2 (en) 2005-04-28 2017-05-16 Proteus Digital Health, Inc. Communication system with partial power source
US9597010B2 (en) 2005-04-28 2017-03-21 Proteus Digital Health, Inc. Communication system using an implantable device
US20150080680A1 (en) * 2005-04-28 2015-03-19 Proteus Digital Health, Inc. Communication System with Partial Power Source
US9439582B2 (en) 2005-04-28 2016-09-13 Proteus Digital Health, Inc. Communication system with remote activation
US8847766B2 (en) * 2005-04-28 2014-09-30 Proteus Digital Health, Inc. Pharma-informatics system
US8816847B2 (en) 2005-04-28 2014-08-26 Proteus Digital Health, Inc. Communication system with partial power source
US20150150480A1 (en) * 2005-04-28 2015-06-04 Proteus Digital Health, Inc. Pharma-informatics system
US10542909B2 (en) 2005-04-28 2020-01-28 Proteus Digital Health, Inc. Communication system with partial power source
US11476952B2 (en) * 2005-04-28 2022-10-18 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
US9161707B2 (en) 2005-04-28 2015-10-20 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US9119554B2 (en) * 2005-04-28 2015-09-01 Proteus Digital Health, Inc. Pharma-informatics system
US8674825B2 (en) 2005-04-28 2014-03-18 Proteus Digital Health, Inc. Pharma-informatics system
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US20150230729A1 (en) * 2005-04-28 2015-08-20 Proteus Digital Health, Inc. Pharma-informatics system
US8730031B2 (en) 2005-04-28 2014-05-20 Proteus Digital Health, Inc. Communication system using an implantable device
US20150223751A1 (en) * 2005-04-28 2015-08-13 Proteus Digital Health, Inc. Pharma-informatics system
US8547248B2 (en) 2005-09-01 2013-10-01 Proteus Digital Health, Inc. Implantable zero-wire communications system
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8956287B2 (en) 2006-05-02 2015-02-17 Proteus Digital Health, Inc. Patient customized therapeutic regimens
US11928614B2 (en) 2006-05-02 2024-03-12 Otsuka Pharmaceutical Co., Ltd. Patient customized therapeutic regimens
US11357730B2 (en) 2006-10-25 2022-06-14 Otsuka Pharmaceutical Co., Ltd. Controlled activation ingestible identifier
US10238604B2 (en) 2006-10-25 2019-03-26 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US8945005B2 (en) 2006-10-25 2015-02-03 Proteus Digital Health, Inc. Controlled activation ingestible identifier
US9083589B2 (en) 2006-11-20 2015-07-14 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US8718193B2 (en) 2006-11-20 2014-05-06 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US9444503B2 (en) 2006-11-20 2016-09-13 Proteus Digital Health, Inc. Active signal processing personal health signal receivers
US8858432B2 (en) 2007-02-01 2014-10-14 Proteus Digital Health, Inc. Ingestible event marker systems
US10441194B2 (en) 2007-02-01 2019-10-15 Proteus Digital Heal Th, Inc. Ingestible event marker systems
US8956288B2 (en) 2007-02-14 2015-02-17 Proteus Digital Health, Inc. In-body power source having high surface area electrode
US11464423B2 (en) 2007-02-14 2022-10-11 Otsuka Pharmaceutical Co., Ltd. In-body power source having high surface area electrode
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US8932221B2 (en) 2007-03-09 2015-01-13 Proteus Digital Health, Inc. In-body device having a multi-directional transmitter
US20100121161A1 (en) * 2007-04-17 2010-05-13 Boston Scientific Scimed, Inc. Ambulatory Urodynamics
US10517506B2 (en) 2007-05-24 2019-12-31 Proteus Digital Health, Inc. Low profile antenna for in body device
US8540632B2 (en) 2007-05-24 2013-09-24 Proteus Digital Health, Inc. Low profile antenna for in body device
US20080302660A1 (en) * 2007-06-07 2008-12-11 Kahn Carolyn R Silicon Electrochemical Sensors
US8197650B2 (en) * 2007-06-07 2012-06-12 Sensor Innovations, Inc. Silicon electrochemical sensors
US8506779B2 (en) * 2007-06-07 2013-08-13 Sensor Innovations, Inc. Electrochemical sensors
US20120067724A1 (en) * 2007-06-07 2012-03-22 Kahn Carolyn R Electrochemical sensors
US9433371B2 (en) 2007-09-25 2016-09-06 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
US8961412B2 (en) 2007-09-25 2015-02-24 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
US9060708B2 (en) 2008-03-05 2015-06-23 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US8542123B2 (en) 2008-03-05 2013-09-24 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US9258035B2 (en) 2008-03-05 2016-02-09 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US8810409B2 (en) 2008-03-05 2014-08-19 Proteus Digital Health, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US8258962B2 (en) 2008-03-05 2012-09-04 Proteus Biomedical, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
US10682071B2 (en) 2008-07-08 2020-06-16 Proteus Digital Health, Inc. State characterization based on multi-variate data fusion techniques
US9603550B2 (en) 2008-07-08 2017-03-28 Proteus Digital Health, Inc. State characterization based on multi-variate data fusion techniques
US11217342B2 (en) 2008-07-08 2022-01-04 Otsuka Pharmaceutical Co., Ltd. Ingestible event marker data framework
US8663105B2 (en) * 2008-08-11 2014-03-04 Nxp, B.V. Ingestible devices for measuring physiological parameters
US20110295079A1 (en) * 2008-08-11 2011-12-01 Nxp B.V. Ingestible devices for measuring physiological parameters
US9415010B2 (en) 2008-08-13 2016-08-16 Proteus Digital Health, Inc. Ingestible circuitry
US8540633B2 (en) 2008-08-13 2013-09-24 Proteus Digital Health, Inc. Identifier circuits for generating unique identifiable indicators and techniques for producing same
US8721540B2 (en) 2008-08-13 2014-05-13 Proteus Digital Health, Inc. Ingestible circuitry
US20100298668A1 (en) * 2008-08-13 2010-11-25 Hooman Hafezi Ingestible Circuitry
US8583227B2 (en) 2008-12-11 2013-11-12 Proteus Digital Health, Inc. Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
US9149577B2 (en) 2008-12-15 2015-10-06 Proteus Digital Health, Inc. Body-associated receiver and method
US8114021B2 (en) 2008-12-15 2012-02-14 Proteus Biomedical, Inc. Body-associated receiver and method
US9659423B2 (en) 2008-12-15 2017-05-23 Proteus Digital Health, Inc. Personal authentication apparatus system and method
US9439566B2 (en) 2008-12-15 2016-09-13 Proteus Digital Health, Inc. Re-wearable wireless device
US8545436B2 (en) 2008-12-15 2013-10-01 Proteus Digital Health, Inc. Body-associated receiver and method
US9883819B2 (en) 2009-01-06 2018-02-06 Proteus Digital Health, Inc. Ingestion-related biofeedback and personalized medical therapy method and system
US8597186B2 (en) 2009-01-06 2013-12-03 Proteus Digital Health, Inc. Pharmaceutical dosages delivery system
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
US9119918B2 (en) 2009-03-25 2015-09-01 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
US9320455B2 (en) 2009-04-28 2016-04-26 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US8545402B2 (en) 2009-04-28 2013-10-01 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US10588544B2 (en) 2009-04-28 2020-03-17 Proteus Digital Health, Inc. Highly reliable ingestible event markers and methods for using the same
US8665035B2 (en) * 2009-05-01 2014-03-04 L-3 Communications Integrated Systems Lp Systems and methods for generating pulsed output signals using a gated RF oscillator circuit
US20100277248A1 (en) * 2009-05-01 2010-11-04 Mcclain Jr Ross A Systems and methods for generating pulsed output signals using a gated RF oscillator circuit
US9149423B2 (en) 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
US8558563B2 (en) 2009-08-21 2013-10-15 Proteus Digital Health, Inc. Apparatus and method for measuring biochemical parameters
US9941931B2 (en) 2009-11-04 2018-04-10 Proteus Digital Health, Inc. System for supply chain management
US8868453B2 (en) 2009-11-04 2014-10-21 Proteus Digital Health, Inc. System for supply chain management
US10305544B2 (en) 2009-11-04 2019-05-28 Proteus Digital Health, Inc. System for supply chain management
US8784308B2 (en) 2009-12-02 2014-07-22 Proteus Digital Health, Inc. Integrated ingestible event marker system with pharmaceutical product
US8396563B2 (en) 2010-01-29 2013-03-12 Medtronic, Inc. Clock synchronization in an implantable medical device system
US8504165B2 (en) 2010-01-29 2013-08-06 Medtronic, Inc. Clock synchronization in an implantable medical device system
US9014779B2 (en) 2010-02-01 2015-04-21 Proteus Digital Health, Inc. Data gathering system
US10376218B2 (en) 2010-02-01 2019-08-13 Proteus Digital Health, Inc. Data gathering system
US9597487B2 (en) 2010-04-07 2017-03-21 Proteus Digital Health, Inc. Miniature ingestible device
US10207093B2 (en) 2010-04-07 2019-02-19 Proteus Digital Health, Inc. Miniature ingestible device
US11173290B2 (en) 2010-04-07 2021-11-16 Otsuka Pharmaceutical Co., Ltd. Miniature ingestible device
US11167059B2 (en) 2010-04-13 2021-11-09 Kci Licensing, Inc. Compositions with reactive ingredients, and wound dressings, apparatuses, and methods
US10529044B2 (en) 2010-05-19 2020-01-07 Proteus Digital Health, Inc. Tracking and delivery confirmation of pharmaceutical products
US11504511B2 (en) 2010-11-22 2022-11-22 Otsuka Pharmaceutical Co., Ltd. Ingestible device with pharmaceutical product
US9107806B2 (en) 2010-11-22 2015-08-18 Proteus Digital Health, Inc. Ingestible device with pharmaceutical product
US8758584B2 (en) 2010-12-16 2014-06-24 Sensor Innovations, Inc. Electrochemical sensors
US9439599B2 (en) 2011-03-11 2016-09-13 Proteus Digital Health, Inc. Wearable personal body associated device with various physical configurations
US11229378B2 (en) 2011-07-11 2022-01-25 Otsuka Pharmaceutical Co., Ltd. Communication system with enhanced partial power source and method of manufacturing same
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US10223905B2 (en) 2011-07-21 2019-03-05 Proteus Digital Health, Inc. Mobile device and system for detection and communication of information received from an ingestible device
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
US9271897B2 (en) 2012-07-23 2016-03-01 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
US9268909B2 (en) 2012-10-18 2016-02-23 Proteus Digital Health, Inc. Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
US11149123B2 (en) 2013-01-29 2021-10-19 Otsuka Pharmaceutical Co., Ltd. Highly-swellable polymeric films and compositions comprising the same
US11744481B2 (en) 2013-03-15 2023-09-05 Otsuka Pharmaceutical Co., Ltd. System, apparatus and methods for data collection and assessing outcomes
US11741771B2 (en) 2013-03-15 2023-08-29 Otsuka Pharmaceutical Co., Ltd. Personal authentication apparatus system and method
US10175376B2 (en) 2013-03-15 2019-01-08 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US11158149B2 (en) 2013-03-15 2021-10-26 Otsuka Pharmaceutical Co., Ltd. Personal authentication apparatus system and method
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10421658B2 (en) 2013-08-30 2019-09-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10097388B2 (en) 2013-09-20 2018-10-09 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9787511B2 (en) 2013-09-20 2017-10-10 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US10498572B2 (en) 2013-09-20 2019-12-03 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9270503B2 (en) 2013-09-20 2016-02-23 Proteus Digital Health, Inc. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US11102038B2 (en) 2013-09-20 2021-08-24 Otsuka Pharmaceutical Co., Ltd. Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping
US9577864B2 (en) 2013-09-24 2017-02-21 Proteus Digital Health, Inc. Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11950615B2 (en) 2014-01-21 2024-04-09 Otsuka Pharmaceutical Co., Ltd. Masticable ingestible product and communication system therefor
US10398161B2 (en) 2014-01-21 2019-09-03 Proteus Digital Heal Th, Inc. Masticable ingestible product and communication system therefor
US10143400B2 (en) * 2014-02-20 2018-12-04 Given Imaging Ltd. In-vivo device using two communication modes
US20160338615A1 (en) * 2014-02-20 2016-11-24 Given Imaging Ltd In-vivo device using two communication modes
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
US10187121B2 (en) 2016-07-22 2019-01-22 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US10797758B2 (en) 2016-07-22 2020-10-06 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
US11793419B2 (en) 2016-10-26 2023-10-24 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers
US11529071B2 (en) 2016-10-26 2022-12-20 Otsuka Pharmaceutical Co., Ltd. Methods for manufacturing capsules with ingestible event markers

Similar Documents

Publication Publication Date Title
US3682160A (en) Physiological signal transmitter for use inside the body
US3971362A (en) Miniature ingestible telemeter devices to measure deep-body temperature
US4689621A (en) Temperature responsive transmitter
US3231834A (en) Telemetering capsule for physiological measurements
US3229684A (en) Telemetering system for physiological measurements
US4844076A (en) Ingestible size continuously transmitting temperature monitoring pill
US3949388A (en) Physiological sensor and transmitter
US4041954A (en) System for detecting information in an artificial cardiac pacemaker
US4372319A (en) Low frequency therapeutic instrument
US4531526A (en) Remote sensor telemetering system
US3872455A (en) Physiological measurement display system
US4370606A (en) Charging apparatus
US3426151A (en) Apparatus for reception of remotely transmitted data utilizing a frequency modulated carrier signal within the audio speech range
US10732734B2 (en) Transmitting type electronic pen and signal transmitting circuit thereof
EP0072003A2 (en) Remote sensor telemetering system
US4185253A (en) Temperature sensitive relaxation oscillator
US3015031A (en) Personal radiation monitor
JPH0115919B2 (en)
JPS6161325B2 (en)
JP2001141512A (en) Physical quantity sensor
GB1288958A (en)
JPH0124711Y2 (en)
JPS6298229A (en) Pressure detector
JPH039650B2 (en)
KR920006250B1 (en) Power source switching system operated by remote control